Clinical requirements for drug therapy in women with iron deficiencies
Iron deficiency anemia (IDA) is characterized by decreased iron levels in the serum, bone marrow and storage pools (spleen, liver, subcutaneous vascular plexus and lungs). IDA is one of the most common pathological conditions in clinical practice, found in 1.8 billion people all over the world [2]....
Main Author: | E. R. Dovletkhanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2014-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/512 |
Similar Items
-
Prevalence of iron deficiency related conditions and the contributing factors
by: A. G. Rumyantsev, et al.
Published: (2015-12-01) -
Current views on iron deficiency anemia in children and treatment optimization
by: O. B. Gordeyeva, et al.
Published: (2014-12-01) -
Anaemia in pregnant women. Principles of therapy today
by: N. A. Korotkova, et al.
Published: (2015-12-01) -
Iron deficiency anemia in pregnant and postpartum women - choosing drugs for treatment
by: N. V. Dubrovina, et al.
Published: (2016-12-01) -
GENERAL ISSUES OF IRON METABOLISM AND PATHOGENESIS OF IRON DEFICIENCY ANEMIA
by: T. E. Potemina, et al.
Published: (2020-11-01)